Heterogeneity and transcriptional drivers of triple-negative breast cancer
Cell Reports · 2023-12 · 42 (12) · 113564
DOI: 10.1016/j.celrep.2023.113564 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-12. Verfasst von Bojana Jovanović und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA…. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, California Breast Cancer Research Program, Ludwig Institute for Cancer Research.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a heterogeneous disease with limited treatment options. To characterize TNBC heterogeneity, we defined transcriptional, epigenetic, and metabolic subtypes and subtype-driving super-enhancers and transcription factors by combining functional and molecular profiling with computational analyses. Single-cell RNA sequencing revealed relative homogeneity of the major transcriptional subtypes (luminal, basal, and mesenchymal) within samples. We found that mesenchymal TNBCs share features with mesenchymal neuroblastoma and rhabdoid tumors and that the PRRX1 transcription factor is a key driver of these tumors. PRRX1 is sufficient for inducing mesenchymal features in basal but not in luminal TNBC cells via reprogramming super-enhancer landscapes, but it is not required for mesenchymal state maintenance or for cellular viability. Our comprehensive, large-scale, multiplatform, multiomics study of both experimental and clinical TNBC is an important resource for the scientific and clinical research communities and opens venues for future investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, M…
- Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA; Department of Stem Cell and Regenerative Bi…
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Harvard-MIT Division of Health Sciences and Technolog…
Förderung
- NCI NIH HHS
- California Breast Cancer Research Program
- Ludwig Institute for Cancer Research
- US Department of Defense Peer Reviewed Cancer Research Program
- Ludwig Center at Harvard
- National Cancer Institute
Zitieren
APA
Jovanović, B., Temko, D., Stevens, L. E., Seehawer, M., Fassl, A., Murphy, K., Anand, J., Garza, K., Gulvady, A., Qiu, X., Harper, N. W., Daniels, V. W., Xiao-Yun, H., Ge, J. Y., Alečković, M., Pyrdol, J., Hinohara, K., Egri, S. B., Papanastasiou, M., …, & Polyak, K. (2023). Heterogeneity and transcriptional drivers of triple-negative breast cancer. Cell Reports, 42(12), 113564. https://doi.org/10.1016/j.celrep.2023.113564
Vancouver
Jovanović B, Temko D, Stevens LE, Seehawer M, Fassl A, Murphy K, et al. Heterogeneity and transcriptional drivers of triple-negative breast cancer. Cell Reports. 2023;42(12):113564. doi:10.1016/j.celrep.2023.113564
BibTeX
@article{Jovanovi2023,
author = {Jovanović, Bojana and Temko, Daniel and Stevens, Laura E and Seehawer, Marco and Fassl, Anne and Murphy, Katherine and Anand, Jayati and Garza, Kodie and Gulvady, Anushree and Qiu, Xintao and Harper, Nicholas W and Daniels, Veerle W and Xiao-Yun, Huang and Ge, Jennifer Y and Alečković, Maša and Pyrdol, Jason and Hinohara, Kunihiko and Egri, Shawn B and Papanastasiou, Malvina and Vadhi, Raga and Font-Tello, Alba and Witwicki, Robert and Peluffo, Guillermo and Trinh, Anne and Shu, Shaokun and Diciaccio, Benedetto and Ekram, Muhammad B and Subedee, Ashim and Herbert, Zachary T and Wucherpfennig, Kai W and Letai, Anthony G and Jaffe, Jacob D and Sicinski, Piotr and Brown, Myles and Dillon, Deborah and Long, Henry W and Michor, Franziska and Polyak, Kornelia},
title = {Heterogeneity and transcriptional drivers of triple-negative breast cancer},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {12},
pages = {113564},
doi = {10.1016/j.celrep.2023.113564}
}
EUVIMED